pLOG

2025-03-12

PatientsForce Recognized as a Premium Provider for PSP Program Management

In Taiwan, the process from obtaining drug approval to securing National Health Insurance (NHI) coverage for new medications often involves a lengthy wait, leaving more patients facing the challenge of out-of-pocket treatment costs. Since 2015, PatientsForce has been committed to providing comprehensive support for these patients. By collaborating with leading pharmaceutical companies, PatientsForce helps patients access necessary treatments while reducing their financial burden.

PatientsForce, along with Zhaizhao Strategy and Tsayox Biotech, has been recognized by renowned pharmaceutical companies, including Pfizer, as a high-quality supplier for Patient Support Programs (PSP). This recognition further establishes PatientsForce as a key long-term partner for global pharmaceutical companies in delivering PSP services.

Excellence in Compliance and Sustainability Gains Global Pharma Trust

PatientsForce prioritizes the stringent requirements of global pharmaceutical companies regarding compliance, sustainability, and information security in supply chain management. In terms of operational management and risk control, the company strengthens quality assurance systems and pharmaceutical safety standards to mitigate potential risks and enhance partnership value.

International Certifications & Quality Assurance
ISO 9001: Quality management system ensuring service stability and standardized processes.
ISO 27001: Information security management system safeguarding confidential data and regulatory compliance.
ISO 27701: Privacy information management system aligning with GDPR and other privacy protection standards.
In addition to delivering exceptional services, PatientsForce actively upholds corporate social responsibility (CSR) through ESG initiatives and has received high ratings in sustainability evaluations:

ESG & Sustainable Development
EcoVadis Certification: Evaluating corporate performance in environmental responsibility, labor rights, ethics, and sustainable procurement.
SBTi SMEs 2030 Net-Zero Initiative: Committing to science-based carbon reduction targets by 2030, in line with global sustainable supply chain trends.
 

PatientsForce’s Value & Commitment

As a trusted long-term partner of global pharmaceutical companies, PatientsForce enhances market value in regulatory compliance, risk management, and sustainable business practices by offering the following key advantages:

Minimizing Operational & Regulatory Risks
Adheres to international certification standards, ensuring data security and privacy compliance.
Enhancing ESG Supply Chain Value
Holds global ESG certifications, demonstrating a strong commitment to sustainability.
Ensuring Long-Term Partnership Stability
Implements robust governance and risk management mechanisms to maintain uninterrupted service delivery. 
 

Scalable Services for Enhancing Patient Well-Being

PatientsForce continues to embrace digital transformation, offering scalable services and building a healthcare support ecosystem to improve service efficiency. With a particular focus on providing comprehensive support for self-pay patients, PatientsForce strives to expand access to medical resources, ensuring more patients receive the care they need.